Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.

Pavithran, KeechilatThomas, Mathew2009-05-282009-05-282005-07-06Pavithran K, Thomas M. Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose. Indian Journal of Dermatology, Venereology and Leprology. 2005 Jul-Aug; 71(4): 288-9http://imsear.searo.who.int/handle/123456789/5317114 references.engAdultAntineoplastic Agents --adverse effectsDose-Response Relationship, DrugDrug Administration ScheduleFollow-Up StudiesHumansLeukemia, Myelogenous, Chronic, BCR-ABL Positive --diagnosisMalePiperazines --adverse effectsPyrimidines --adverse effectsSeverity of Illness IndexStevens-Johnson Syndrome --chemically inducedImatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.Case Reports